University of North Carolina (UNC)

Site:	University of North Carolina (UNC)
Address:
City:	Chapel Hill
State:	NC
Zip:	27157
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
2	Study of LOXO-101 in Subjects With NTRK Fusion Positive Solid Tumors	Recruiting	Active, not recruiting	LOXO-101	NCT02576431
2	Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study	Active, not recruiting	Closed	CB-839	NCT03872427